Modified non-overt DIC diagnostic criteria predict the early phase of overt-DIC

American Journal of Hematology

Volumn 85, Issue 9, 2010, Pages 691-694

  Wada, Hideo ^a   Hatada, Tsuyoshi ^a   Okamoto, Kohji ^b   Uchiyama, Toshimasa ^c   Kawasugi, Kazuo ^d   Mayumi, Toshihiko ^e   Gando, Satoshi ^f   Kushimoto, Shigeki ^g   Seki, Yoshinobu ^h   Madoiwa, Seiji ⁱ   Okamura, Takashi ^j   Toh, Cheng Hock ^k  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c National Hospital Organization   (Japan)

^d TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g NIPPON MEDICAL SCHOOL   (Japan)

^h Department of Internal Medicine   (Japan)

ⁱ JICHI MEDICAL UNIVERSITY   (Japan)

^j KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AGED; BLOOD; BLOOD CLOTTING TEST; CLINICAL TRIAL; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HEMOSTASIS; HUMAN; MALE; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD COAGULATION TESTS; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 77956479530     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21783     Document Type: Article

References (20)

1. Colman RW, Robby SJ, Minna JD. Disseminated intravascular coagulation (DIC): An approach. Am J Med 1972;52:679-689.
2. Kobayashi N, Maegawa T, Takada M, et al. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haematol 1983;49:265-275.
3. Taylor FB Jr, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation - On behalf of the Scientific Subcommittee on disseminated intravascular coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Thromb Haemost 2001;86:1327-1330.
4. Wada H, Gabazza EC, Asakura H, et al. Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): Diagnostic criteria of the international society of thrombosis and haemostasis (ISTH) and of the Japanese Ministry of Health and Welfare for overt DIC. Am J Hematol 2003;74:17-22.
5. Warren BL, Eid A, Singer P, et al. High-dose antithrombin in severe sepsis. A randomized controlled trial. JAMA 2001;286:1869-1878.
6. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human protein C for severe sepsis. N Engl J Med 2001;8:699-709.
7. Abraham E, Reinhart K, Opal S, et al. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: A randomized controlled trial. JAMA 2003;290:238-247.
8. Wada H, Wakita Y, Nakase T, et al. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Thromb Haemost 1995;74:848-852.
9. Toh CH, Hoots WK. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: A 5-year overview. J Thromb Haemost 2007;5:604-606.
10. Hayakawa M, Gando S, Hoshino H. A prospective comparison of new Japanese criteria for disseminated intravascular coagulation: New Japanese criteria versus ISTH criteria. Clin Appl Thromb Hemost 2007;13:172-181. (Pubitemid 46548377)
11. Egi M, Morimatsu H, Wiedermann CJ, et al. Non-overt disseminated intravascular coagulation scoring for critically ill patients: The impact of antithrombin levels. Thromb Haemost 2009;101:696-705.
12. Toh CH, Downey C. Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2005;16:69-74.
13. Wada H, Gabazza EC, Nakasaki T, et al. Diagnosis of disseminated intravascular coagulation by hemostatic molecular markers. Semin Thromb Hemost 2000;26:17-22.
14. Wada H, Sakuragawa N, Shiku H. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients. Semin Thromb Hemost 1998;24:293-297.
15. Wada H, Asakura H, Okamoto K, et al. Expert consensus for the treatment of disseminated intravascular coagulation in Japan. Thromb Res 2010;125:6-11.
16. Gando S, Kameue T, Nanzaki S, Nakanishi Y. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemost 1996;75:224-228.
17. Wada H, Yamamuro M, Inoue A, et al. Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. coli sepsis - Toward a distinct between uncompensated overt DIC and compensated non-overt DIC. Thromb Haemost 2001;86: 1489-1494.
18. Asakura H, Ontachi Y, Mizutani T, et al. Decreased plasma activity of antithrombin or protein C is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation. Eur J Haematol 2001;67:170-175. (Pubitemid 33105057)
19. Wada H. Disseminated intravascular coagulation. Clin Chim Acta 2004;344:13-21.
20. Kinasewitz GT, Zein JG, Lee GL, et al. Prognostic value of a simple evolving disseminated intravascular coagulation score in patients with severe sepsis. Crit Care Med 2005;33:2214-2221.